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ABSTRACT 
 
A large and diverse array of small hydrophobic molecules induce general anesthesia.  Their 
efficacy as anesthetics has been shown to correlate both with their affinity for a hydrophobic 
environment and with their potency in inhibiting certain ligand gated ion channels.  Here we 
explore the effects that n-alcohols and other liquid anesthetics have on the two-dimensional 
miscibility critical point observed in cell derived giant plasma membrane vesicles (GPMVs).  We 
show that anesthetics depress the critical temperature (Tc) of these GPMVs without strongly 
altering the ratio of the two liquid phases found below Tc.  The magnitude of this affect is 
consistent across n-alcohols when their concentration is rescaled by the median anesthetic 
concentration (AC50) for tadpole anesthesia, but not when plotted against the overall 
concentration in solution.  At AC50 we see a 4°C downward shift in Tc, much larger than is 
typically seen in the main chain transition at these anesthetic concentrations.  GPMV miscibility 
critical temperatures are also lowered to a similar extent by propofol, phenylethanol, and 
isopropanol when added at anesthetic concentrations, but not by tetradecanol or 2,6 
diterbutylphenol, two structural analogs of general anesthetics that are hydrophobic but have no 
anesthetic potency.  We propose that liquid general anesthetics provide an experimental tool for 
lowering critical temperatures in plasma membranes of intact cells, which we predict will reduce 
lipid-mediated heterogeneity in a way that is complimentary to increasing or decreasing 
cholesterol.  Also, several possible implications of our results are discussed in the context of 
current models of anesthetic action on ligand gated ion channels. 
 
INTRODUCTION  
 
A large number of small molecules induce clinically similar general anesthesia, ranging from the 
noble gas Xenon to larger organic molecules. Since the early 20th century it has been known that 
the potency of a general anesthetic is roughly proportional to its oil:water partition coefficient 
over more than five orders of magnitude in overall concentration (3).   This striking correlation 
along with the structural diversity of general anesthetics has led many to speculate that 
anesthesia is induced through non-specific effects on the physical properties of membrane lipids, 
and not through specific interactions with proteins.  It has been proposed that this could be 
accomplished by altering the pressure profile of the membrane (4), the lateral organization of the 
membrane (5, 6), or the mechanical properties of axonal membranes (7).  In support of these 
theories, general anesthetics were shown to decrease lipid chain ordering (8), increase membrane 
fluidity (9) and lower the transition temperature into a gel phase (10, 11).   
 
Strong arguments have been made against membrane-mediated models of general anesthesia 
over the past several decades.  First, although anesthetics do partition into membranes roughly in 
proportion to their potency (12), there are a variety of hydrophobic small molecules that partition 
strongly into membranes but have reduced or no anesthetic potency, some of which are structural 
analogs of well characterized anesthetics (8, 13-15).  Second, it has been argued that the effects 
that anesthetics have on the physical properties of membranes are too small to be functionally 
significant at their anesthetic dose, as many properties are easily mimicked by raising 
temperature <1°C (16).   
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Instead, recent attention has focused on protein models.   It is now well known that the function 
of many ligand gated ion channels are sensitive to the presence of anesthetics (17) and it is 
widely (though not universally, see for example (7, 18, 19)) held that the anesthetic response is 
primarily due to the altered functioning of these ligand-gated channels.  Recent experiments have 
shown that this sensitivity can be modulated by mutating specific amino acid residues (20).  A 
recent crystallographic study has localized anesthetics in the vicinity of a proposed binding site 
of GLIC, a prokaryotic ligand gated ion channel that is sensitive to anesthetics, although the 
resulting structure most closely resembles the anesthetic destabilized ‘open’ state (21).  These 
and other related results are widely interpreted to imply that anesthetics exert their influence on 
channels by binding to specific sites on target molecules. 
 
In parallel, the past decade has clarified the functional roles of lipids in biological processes at 
the plasma membrane of animal cells.  Relevant to the current study, it is now believed that 
proteins are not uniformly distributed in mammalian cell membranes, but that lipids help to 
laterally organize proteins into correlated structures with dimensions ranging between 10 and 
100nm often termed lipid rafts or lipid shells (22-24).  These structures likely arise, at least in 
part, because plasma membranes can separate into two equilibrium liquid phases at low 
temperatures, called liquid-ordered (Lo) and liquid-disordered (Ld) (25).  We have recently 
proposed a model of plasma membrane heterogeneity that attributes this structure to the presence 
of a miscibility critical point in cell plasma membranes below growth temperatures (1, 26-28).  
This model is supported by experimental observations of critical behavior in giant plasma 
membrane vesicles (GPMVs) isolated from living cells (29, 30).  This shares essential elements 
of earlier models that focus on fluctuations in single component bilayer membranes in the 
vicinity of the gel-liquid transition (26, 27) or in single or multicomponent monolayer 
membranes near a miscibility critical point (28, 31, 32).  All of these models predict that the size, 
composition, and life-time of lipid mediated structures in intact cells at physiological 
temperature will be sensitive to the temperature of the underlying critical point.   
 
In this study, we explore how liquid general anesthetics modulate the miscibility transition in 
plasma membrane vesicles isolated from RBL-2H3 cells.  This work is motivated by past 
experiments in purified model membranes that demonstrate the miscibility transition can be 
sensitive to small perturbations in composition (33-37).  We find that most liquid general 
anesthetics investigated lower critical temperatures in GPMVs by roughly 4°C at their anesthetic 
dose, and by larger amounts at higher concentrations.  This modulation is expected to reduce the 
magnitude of heterogeneity in plasma membranes at physiological temperature, and could in 
principle suppress the functions of proteins or protein networks that are sensitive to lipid-
mediated structures.  There is some evidence that the localization and function of ligand gated 
ion channels, including some implicated in the anesthetic response are sensitive to ‘raft’ 
heterogeneity (38-42).  This suggests that anesthetics may act, at least in part, through their 
effects on membrane miscibility. 
 
MATERIALS AND METHODS  
 
Materials:   
Rat basophilic leukemia (RBL-2H3) cells were a gift from Barbara Baird and David Holowka. 
The fluorescent probe DiI-C12 was purchased from Life Technologies (Carlsbad, CA). 
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Formaldehyde was obtained from Thermo Fisher Scientific (Waltham, MA). Diththiothreitol, 
ethanol, 1-propanol, 2-propanol, octanol, decanol, tetradecanol, propofol, phenylethanol, 2,6 
ditertbutylphenol, dimethylsulfoxide (DMSO), and all additional reagents unless otherwise 
specified were purchased from Sigma Aldrich (St. Louis, MO). 
 
Cells and GPMV preparation: 
RBL-2H3 cells were grown and maintained with media containing MEM, 20% FBS, 10 μg/ml 
gentamicin sulfate in 25cm2 flasks as described previously (43).  Cells were labeled for 10min 
with 2μg/mL DiI-C12 in methanol (1% final concentration) then GPMVs were prepared as 
described previously (25), by incubating cells in a buffer containing 2mM DTT, 25mM 
formaldehyde, 150mM NaCl, 2mM CaCl2, and 20mM HEPES pH 7.4 at 37°C for 60min, after 
which they were isolated by separating buffer from adherent cells. GPMVs were treated for five 
minutes with anesthetics at the specified concentrations by diluting GPMV suspensions at most 
1:1 into buffer containing anesthetics for at least 15 min prior to imaging.  In control experiments 
(no anesthetic added) we observe no effect of diluting GPMV suspensions into additional buffer.  
Tetradecanol and 2,6 ditert-butylphenol were dissolved in DMSO prior to being added to 
GPMVs because these compounds have low water solubility. The maximum final concentration 
of DMSO was 14mM.  Significantly higher DMSO concentrations (600mM) did not alter results 
in control experiments, and results were indistinguishable within error for GPMVs incubated 
with 11µM propofol in the presence or absence of 14mM DMSO. 
 
Fluorescence microscopy: 
GPMVs were imaged between two #1.5 coverslips sealed with a thin layer of Dow Corning high 
vacuum grease.  Images were acquired using an inverted microscope (IX81; Olympus, Center 
Valley, PA) using a 40X 0.95 NA air objective, a Cy3 filter-set (Chroma Technology, Bellows 
Falls, VT) and an SCMOS camera (Neo; Andor, South Windsor, CT). The sample chamber was 
attached to a homebuilt temperature stage consisting of a peltier thermoelectric device, water-
circulating heat sink (Custom Thermoelectric, Bishopville, MD), and a PID-type controller unit 
(Oven Industries, Mechanicsburg, PA). The sample was adhered using a thin layer of thermal 
grease to a copper plate in thermal contact with one side of the peltier device. Temperature was 
measured with a thermister probe mounted on the copper plate close to the sample. 
 
Transition temperature determination: 
Several (typically 5) fields containing numerous GPMVs (10-200) from the same sample were 
imaged at temperatures ranging from 25°C to 5°C in increments of 2 to 3°C. At each 
temperature, 200 to 500 GPMVs were imaged. The percent of GPMVs containing two coexisting 
liquid phases (%separated) was determined from images acquired at each temperature (T) using 
a custom program written in Matlab (MathWorks, Natick, MA) and errors are given by counting 
statistics. Critical temperatures (TC) are obtained through a nonlinear least squares fit to the 
following sigmoidal curve: 
%𝑠𝑒𝑝𝑒𝑟𝑎𝑡𝑒𝑑 = 100 × �1 − 1
1+𝑒−(𝑇−𝑇𝐶)/𝐵�, 
where B is a constant that describes the slope of the curve at the transition temperature.  By this 
definition, TC corresponds to the temperature where fifty percent of vesicles contain coexisting 
liquid phases. Errors in absolute transition temperatures (σT) for a single measurement are 
extracted directly from the fit.   
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Absolute critical temperatures for GPMV preparations can show significant day-to-day variation, 
therefore we report critical temperature shifts in the presence of anesthetics compared to a 
control sample investigated from the same preparation of GPMVs.  The error bounds for a given 
critical temperature shift (ΔTC) is given by 𝜎Δ𝑇𝐶 = �𝜎𝑇02+𝜎𝑇2, 
where 𝜎𝑇0 is the error associated with determining the critical temperature of the control sample 
and 𝜎𝑇 is the error associated in determining the critical temperature of GPMVs with anesthetic.  
In most cases, we report a critical temperature shift that is a weighted average of ΔTC values 
determined from multiple experiments conducted on different days (typically 3-4). Weights are 
given by 𝑤 = 1
𝜎𝑖2
∑ 1
𝜎𝑖2
� , where σi is the error for each ΔTC included in the average.  Error bounds 
on average points (σ) are given by 𝜎 = �1 ∑ 1
𝜎𝑖2
� . 
 
 
RESULTS 
 
Ethanol lowers critical temperatures in isolated plasma membrane vesicles. 
 
Giant plasma membrane vesicles (GPMVs) isolated from RBL-2H3 cells contain a single liquid 
phase at elevated temperatures and coexisting liquid-ordered (Lo) and liquid-disordered (Ld) 
phases at low temperatures.  Phase separation is easily visualized by monitoring the lateral 
distribution of the fluorescent lipid analog DiI-C12 in GPMVs using conventional fluorescence 
microscopy. While individual GPMVs have well defined transition temperatures, there is 
significant variation in transition temperatures between vesicles isolated from a single flask of 
cells.  For this reason, we report the average transition temperature for a sample of GPMVs by 
determining the fraction of vesicles containing coexisting phases as a function of temperature, as 
shown in Fig.1.  This distribution is fit to a sigmoid function to extract the temperature where 
50% of vesicles have undergone a transition, which we report as the transition temperature of the 
sample.  For the control sample in Fig. 1 A, we extract an average transition temperature of 
15.9±0.3°C, where the error is extracted directly from the fit. 
 
When GPMVs isolated from the same dish of cells are incubated with ethanol prior to imaging, 
we observe the average transition temperature at a lower value.  For the case of 120mM ethanol 
shown in Fig. 1 A, we measure an average transition temperature of ethanol treated GPMVs to be 
12.5±0.6°C, which represents a downwards shift of ΔTC = -3.4±0.7°C compared to untreated 
vesicles.  This shift in average transition temperature is most apparent when vesicles are 
visualized at a temperature where a finite fraction of vesicles are phase separated in untreated 
GPMVs. When ethanol treated vesicles are imaged at this same temperature, many fewer 
vesicles contain coexisting liquid phases.  We also find that the magnitude of ΔTC depends on 
the concentration of anesthetic incubated with GPMVs.  Fig. 1 B shows the fraction of phase 
separated GPMVs as a function of temperature for control GPMVs and GPMVs incubated with 
120mM, 240mM, or 600mM ethanol prior to imaging, with all GPMVs prepared from the same 
flask of cells.  Extracted transition temperatures are shown in Fig. 1 C and are monotonically 
decreasing with increasing ethanol concentration, with nonlinearities at low concentrations. 
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In addition to variation of transition temperatures between vesicles in a given GPMV 
preparation, we also observe significant day to day variation when average transition 
temperatures are measured.  This is demonstrated by comparing the control curves in Fig. 1, A 
and B, which yield different absolute transition temperatures (15.9±0.3°C vs. 20.3±0.6°C).  Even 
so, we find that the magnitude of the downward shift in transition temperatures observed after 
the addition of liquid general anesthetics is robust.  For the example of incubation with 120mM 
ethanol, we observe an average transition temperature shift of ΔTC = -3.5±0.6°C when averaged 
over 3 distinct experiments, where the error is the standard deviation between the three 
measurements.  
 
 
 
FIG. 1: Ethanol lowers transition temperatures in GPMVs. (A) Untreated 
GPMVs isolated from a single flask of cells show a broad distribution of transition 
temperatures.  We quantify average transition temperatures by measuring the 
fraction of GPMVs with coexisting phases at multiple temperatures (black points) 
and fit this distribution to extract the temperature where 50% of GPMVs contain 
coexisting liquid phases.  When ethanol (EtOH) is added to vesicles from the same 
flask of cells prior to imaging, the distribution of phase separated vesicles shifts to 
a lower temperature (red points), indicating that the transition temperature is lower.  
This downward shift in transition temperature is most apparent when comparing 
fields of vesicles imaged at 14°C in this experiment, where the majority of control 
GPMVs contain coexisting liquid phases whereas most ethanol treated vesicles are 
uniform.  (B, C) The transition temperature shift is dependent on the concentration 
of ethanol incubated with GPMVs.  The curves in B are fit to obtain the average 
transition temperature reported in C and are drawn with the same symbols. 
6 
 
Ethanol treated vesicles retain critical fluctuations 
 
In addition to undergoing a miscibility transition near room temperature, untreated GPMVs 
exhibit robust critical fluctuations within several degrees of their miscibility transition 
temperature. The size and contrast of fluctuations in both synthetic and isolated biological 
membranes have been previously shown to be consistent with belonging to the 2D Ising model 
universality class (29, 44).  Hallmarks of criticality in membranes include micron-sized and 
dynamic composition fluctuations within ~1°C above the miscibility transition temperature and 
undulating phase boundaries within several degrees below the miscibility transition temperature 
(44, 45).  Vesicles with critical compositions also contain roughly equal surface fractions of 
phases at temperatures just below the phase transition.  Untreated vesicles show weak 
temperature dependence in the surface fraction of coexisting phases, consistent with their being a 
nearly vertical rectilinear diameter (1).  
 
While incubation with different concentrations of ethanol lowers transition temperatures in 
GPMVs, hallmarks of critical behavior are still observed in these vesicles, albeit at a lower 
temperature, as shown in Fig. 2. Ethanol treated vesicles can be found to contain large and 
dynamic composition fluctuations above their transition temperature, undulating phase 
boundaries below their transition temperature, and roughly equal surface fractions of phases in 
vesicles well below their phase transition temperature.  These results suggest that although 
membrane composition is altered through incubation with ethanol, this composition change acts 
to shift the critical temperature without shifting vesicle composition away from a critical 
composition 
 
 
 
FIG. 2: Ethanol treated vesicles retain critical fluctuations.  Representative images 
of different GPMVs imaged in 120mM ethanol demonstrating a range of critical 
phenomena including dynamic super-critical fluctuations for T≥TC and phase 
boundary fluctuations for T≤TC.  At low temperatures (T<<TC), vesicles separate into 
roughly equal surface fractions of liquid-ordered and liquid-disordered phases.  
Vesicle imaged over a range of temperatures between 11°C and 16°C. 
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Liquid alcohol anesthetics lower critical temperatures by 4°C at their anesthetic dose. 
 
Ethanol is a member of a series of n-alcohol general anesthetics, and we have also investigated 
how other compounds in this series modulate phase transition temperatures and fluctuations in 
isolated GPMVs.  As summarized in Fig. 3 A, all n-alcohol anesthetics investigated lower critical 
temperatures in GPMVs compared to untreated vesicles isolated from the same flask of cells 
although the concentration required depends strongly on the alcohol used. Longer chain alcohols 
such as octanol or decanol are the most potent. Similar to ethanol, GPMVs treated with longer 
chain n-alcohols also retain hallmarks of critical behavior near and below their transition 
temperature.  As a control, we investigated GPMVs incubated with DMSO, where we observe no 
shift in transition temperatures when DMSO is included at 600mM.  
 
Remarkably, plots of ΔTC vs. n-alcohol concentration collapse onto a single curve within error 
when n-alcohol concentration is re-scaled by their anesthetic potency, as shown in Fig. 3 B.  The 
anesthetic dose, or AC50 value, is defined as the anesthetic concentration where 50% of tadpoles 
lose their righting reflex, as reported in a previous study (2). AC50 values for the n-alcohols 
investigated are 120mM (ethanol), 54mM (isopropanol), 60µM (octanol), and 13µM (decanol).  
For all compounds, we observe a downward shift of 4°C when added at their anesthetic dose.  
We note that this is significantly larger than the ~1°C downward shift observed in the main chain 
transition temperature of DPPC with the same concentration of n-alcohol anesthetic (16).  
 
FIG. 3: Critical temperature shift in GPMVs scales with anesthetic potency.  
(A) Measured critical temperature shifts in GPMVs incubated with a series of n-
alcohol general anesthetics as a function of aqueous concentration of n-alcohol.  
Data points represent a weighted average over multiple experiments, as described in 
Methods and error bounds are propagated through this average. Lines are fits to all 
points excluding 0mM n-alcohol.  (B) Data from A repotted with concentration 
scaled by the published anesthetic dose (AC50) of these compounds (2).   
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Non n-alcohol anesthetics also lower critical temperatures at their anesthetic dose. 
 
In order to explore if our observations regarding n-alcohols could be generalized to other liquid 
anesthetics, we also investigated the impacts of three additional anesthetic compounds in Fig. 4.  
Isopropanol is an isomer of 1-propanol, and has a slightly reduced concentration required for 
blocking power on motor fibers from sciatic nerves of frogs (351mM vs. 218mM) (46).  If we re-
scale this value using the AC50 value for 1-propanol to influence the righting reflex of tadpoles, 
we estimate an AC50 value for isopropanol to be 87mM, as indicated on Fig. 4 A.  At this 
concentration, the critical temperature is depressed by ~4°C, as is seen for n-alcohol anesthetics.  
Phenylethanol (PEtOH) is a local anesthetic which has been previously demonstrated to alter 
helix aggregation in bacterial membranes and single component model membranes (47).  Again, 
we observe that adding PEtOH to GPMVs acts to reduce critical temperatures, with a 4°C 
downward shift at approximately 25mM.  At a possibly more clinically relevant concentration of 
8mM (47), we observe a downward shift of 2.5±0.4°C.  Finally, we explored the intravenous 
general anesthetic propofol, and again find that propofol lowers critical temperatures when added 
to GPMVs.  Previous work has measured an AC50 value of between 2.2 and 2.5µM (48), and at 
this concentration we observe a 2.1±0.3°C downward shift in GPMV critical temperature.   For 
all three compounds, we observe a linear concentration dependence with a negative y-intercept 
of about -2°C as was observed with other n-alcohols, indicating nonlinearity at low 
concentrations.  Overall, we find that these compounds reveal the same pattern observed for n-
alcohol anesthetics, although in some cases the magnitude is reduced. 
 
FIG. 4: Non n-alcohol liquid anesthetics lower critical temperatures at their 
anesthetic dose. Data points represent a weighted average over at least two 
separate experiments and error bounds are propagated through this average, as 
described in Methods. Lines are fits to all points excluding 0mM for 
phenylethanol and propofol and <50µM for isopropanol.  The estimated anesthetic 
doses for these compounds are indicated by dashed lines and are determined as 
described in the main text. 
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Membrane soluble molecules that are not anesthetics do not lower critical temperatures. 
 
There are numerous hydrophobic small molecules that are structurally similar to general 
anesthetics, but do not exhibit any general anesthetic activity.  One well-studied example is long 
chain n-alcohols with n≥12. This so-called ‘anesthetic cutoff effect’ has been used to argue 
against a lipid-mediated mechanism of general anesthesia (e.g. (13, 15)).  Fig. 5 A shows that 
tetradecanol (n=14) does not alter critical temperatures in GPMVs even when added at 
concentrations up to 5µM, which is the measured AC50 value for dodecanol (n=12).  A second 
example of a hydrophobic small molecule without anesthetic activity is 2,6 diterbutylphenol (15) 
and is shown in Fig. 5 B.  2,6 diterbutylphenol is structurally similar to propofol but contains two 
additional methyl groups and is therefore more hydrophobic.  Similar to tetradecanol, we again 
observe no shift in critical temperatures when 2,6 diterbutylphenol is added to suspensions of 
GPMVs, even at concentrations where propofol decreases TC by roughly 4°C.   
 
 
DISCUSSION  
 
Our observation that liquid general anesthetics lower critical temperatures in isolated GPMVs 
suggest that these compounds could be a useful experimental tool for probing the effects of lipid-
mediated heterogeneity in a range of cellular processes.  Within the critical fluctuation model of 
plasma membrane heterogeneity, a compound that acts to lower TC would also reduce the size, 
 
FIG. 5 Structurally similar non-anesthetics do not lower critical temperatures.  
(A) Tetradecanol is an n-alcohol but is not active as a general anesthetic. 
Tetradecanol does not lower critical temperatures when added to GPMVs.  n-alcohol 
data for n≤10 is re-plotted from Fig. 3 C. (B) 2,6 diterbutylphenol is structurally 
similar to propofol but contains two additional methyl groups and is not active as a 
general anesthetic.  2,6 diterbutylphenol does not lower critical temperatures in 
GPMVs.  Propofol data re-plotted from Fig. 4 C. 
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lifetime, and compositional contrast of lipid-mediated domains in the plasma membrane at 
physiological temperature.  In this context, liquid general anesthetics are expected to act as 
inhibitors of lipid heterogeneity, and should interfere with the functioning of proteins or protein 
networks that exploit this type of lipid structure to perform their cellular functions. Unlike 
cholesterol reduction, which modulates the miscibility transition in GPMVs by reducing the 
surface fraction of the liquid-ordered phase (30, 49), liquid general anesthetics alter membrane 
mixing properties while maintaining membranes at a critical composition.  We expect anesthetics 
to be useful as a complimentary membrane perturbation to the commonly used cholesterol 
modulation, by perturbing lipid mediated heterogeneity through an alternate mechanism (Fig. 6).  
Anesthetics may produce results that are easier to interpret as lipid mediated interactions will be 
reduced without changing the surface area available to compounds that have a strong preference 
for either the liquid-ordered or liquid-disordered phase.  In addition, liquid general anesthetics 
 
 
FIG. 6: (A) Proposed schematic phase diagram of a cell membrane. Normal 
physiological conditions (grey circle) reside above a miscibility critical point (star) 
below which the membrane separates into coexisting Lo and Ld phases.  Contours are 
of constant correlation length as described previously (1) and physiological conditions 
predicted to have a correlation length of roughly 20nm. At constant physiological 
temperature, addition of general anesthetics is expected to shift membranes in the 
direction of the red arrow (1), increasing the temperature difference from the critical 
point.  The more familiar perturbations of cholesterol depletion (loading) act to 
decrease (increase) membrane order, acting like the green (red) arrows on the phase 
diagram marked 2 and 4. (B) Perturbations affect the lateral structure of the membrane 
as depicted schematically with snapshots from a lattice Ising model, which shares 
broad features of its phase diagram.  Under physiological conditions (3), there is no 
macroscopic phase separation, but super-critical fluctuations lead to structure that is 
much larger than the size of microscopic components, and there is roughly an equal 
area of ordered and disordered components.  The common perturbations of cholesterol 
depletion (2) and loading (4) primarily act to increase the surface fraction of disordered 
(white) or ordered (black) membrane respectively.  In contrast, liquid general 
anesthetics perturb membrane structure, but do not affect the ordered to disordered 
ratio (1).  Instead they reduce the size, lifetime and contrast of fluctuations.      
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alter membrane mixing properties without the large changes in global membrane composition 
that accompany cholesterol reduction, since cholesterol typically makes up ~40 mol% of the 
intact plasma membrane (50).  
 
In the context of general anesthesia, our findings contribute to the current discussion regarding 
the molecular mechanisms through which liquid general anesthetics act on ligand gated ion 
channels.  Within a model where general anesthetics act primarily through direct binding to 
ligand gated ion channels, our results indicate that these ligands also act to lower critical 
temperatures in membranes.  More generally, we can infer that liquid general anesthetics 
partition to the interface between ordered and disordered liquid domains because these 
compounds lower the miscibility transition temperature without changing the surface fraction of 
low temperature phases (51).  If ligand gated ion channels also localize to the interface, this 
could be a means to increase the local concentration of ligands close to the binding site, as has 
been noted previously (5).  Alternately, a channel could alter its partitioning through the binding 
of anesthetic ligands if these compounds retain their phase preference upon binding to target 
proteins.  Our observations using synthetic liquid anesthetics also suggest that endogenous 
ligands for these sites may also share the property that they lower critical temperatures in plasma 
membranes and localize to domain boundaries.  It is possible that putative anesthetic sites 
provide a means of coupling membrane properties to the functioning of proteins. 
 
We find it striking that the TC lowering effect scales remarkably well with anesthetic potency for 
the four n-alcohol general anesthetics investigated.  To first order, this is the expected result 
because n-alcohols become more hydrophobic as n is increased and therefore partition more 
strongly into membranes (12).  However, this striking correlation extends beyond the n-alcohol 
anesthetics to include tetradecanol, an n-alcohol which is expected to strongly partition into 
membranes but has no anesthetic potency. We observe no downward shift in TC in membranes 
containing tetradecanol, in good agreement with previous ESR studies which demonstrated that 
tetradecanol does not alter the ordering of natural membranes even at much higher membrane 
concentrations (8). TC is also not altered when the propofol analog 2,6 diterbutylphenol is added 
to GPMVs, again consistent with it lacking anesthetic activity. For the molecules investigated 
here, the shift in TC more accurately predicts general anesthetic potency than does membrane 
partitioning.  
 
We observe a much larger shift in Tc than is expected from a naïve extrapolation of results in 
other membrane assays, which typically show changes that can be mimicked by very small 
(<1K) changes in temperature (16).  The magnitude of the anesthetic effect on the miscibility 
transition in GPMVs also highlights the differences between the membrane miscibility transition 
examined here and the main chain melting transition present in single-component membranes, 
where transition temperatures are reduced in the presence of anesthetic through freezing point 
depression.  Previous work has demonstrated that miscibility transitions are generally more 
sensitive to perturbations in the form of impurities (33-36, 52).  The miscibility transition in 
GPMVs is also different than the main chain transition in purified membranes in that it is a 
continuous, second order transition, tuned very close to its critical point (Fig. 6).  The miscibility 
critical point is distinguished by an increased sensitivity of physical properties to changes in its 
reduced temperature and composition.  Thus, a small shift in Tc could lead to large changes in 
physical properties at a fixed temperature.   
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Our results hint at the intriguing possibility that anesthetics may exert some of their influence on 
proteins through their effects on the membrane’s miscibility behavior.  Plasma membrane 
composition has been implicated in controlling the spatial localization of membrane receptors 
and channels (38), and there is evidence that many channels including those implicated in the 
anesthetic response are localized in this fashion, including the gamma aminobutyric acid A 
(GABA-A) receptor (41) and nicotinic acetylcholine receptor (nAchR) (53).   It is also possible 
that localization is tied in some way to function, either by providing a local lipid environment 
that either promotes or suppresses channel activation, by bringing receptors into close proximity 
with regulatory components, or by tuning the interactions between components of a regulatory 
network (see (54) and Fig. 6).  Along these lines, it has been shown that plasma membrane 
cholesterol levels modulate the functioning many ion channels (38), including both GABA-A 
(42) and nAchR (40), although these changes could be mediated by direct binding to cholesterol 
or by specific interactions with neurosteroid modulators (55).   
 
In principle, an ion channel regulated through its preferences for a local lipid environment could 
have its gating properties changed by any perturbation that modulates the mixing properties of 
lipids, even without specific binding of these compounds to the channels themselves.  This 
includes liquid general anesthetics, which we demonstrate in this study to lower critical 
temperatures in isolated plasma membranes. Further experimental and modeling work is required 
to clarify if this type of regulation plays an important role in the specific case of functioning of 
the ligand gated ion channels responsible for general anesthesia, and if the 4°C shift observed in 
our study is adequate to significantly impact receptor functions.  More generally, we expect that 
liquid general anesthetics will interfere with the large number of biological processes that have 
already been postulated to make use of membrane ‘raft’ heterogeneity to compartmentalize and 
organize their function.   
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